Provided By GlobeNewswire
Last update: Jul 22, 2025
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the extinguishment of its convertible note with YA II PN, Ltd (“Yorkville”).
Read more at globenewswire.comNASDAQ:COEP (11/12/2025, 3:52:34 PM)
14.805
+0.5 (+3.53%)
Find more stocks in the Stock Screener


